Clinical Trial Update: The Protective Effect for Liver Organ in Patients With Anti-TB Drugs Using of Acetylcysteine (NAC) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating whether N-acetylcysteine protects the liver in patients receiving anti-tuberculosis drugs to prevent drug-induced liver inju…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Drug-induced Liver Injury
• Tuberculosis

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Far Eastern Memorial Hospital | Conditions: Protective Effect in TB-DIH, TB-DIH Means: Drug Induced Liver Function Abnormalities | Phase 4 | Status: UNKNOWN